Hepatitis B virus reactivation in a case of Non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy

Leukemia and Lymphoma

Volumn 45, Issue 3, 2004, Pages 627-629

  Tsutsumi, Yutaka ^a   Kawamura, Takahito ^a   Saitoh, Shin ^a   Yamada, Masahiro ^a   Obara, Shinji ^a   Miura, Takuya ^a   Kanamori, Hiroe ^a   Tanaka, Junji ^b   Asaka, Masahiro ^b   Imamura, Masahiro ^b   Masauzi, Nobuo ^a  

^a Hakodate Municipal Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis; Hepatitis B virus (HBV); Lamivudine; Non Hodgkin's lymphoma (NHL); Rituximab

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE; GLYCYRRHIZIC ACID; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PREDNISOLONE; RITUXIMAB; URSODEOXYCHOLIC ACID; VINCRISTINE;

ADVANCED CANCER; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CASE REPORT; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LABORATORY TEST; LIVER DYSFUNCTION; LIVER FAILURE; NONHODGKIN LYMPHOMA; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; VIRUS REACTIVATION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER FAILURE; LYMPHOMA, NON-HODGKIN; SEROLOGIC TESTS; VIRUS ACTIVATION;

EID: 10744227909     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000151923     Document Type: Article

References (12)

1. Reff, M.E., Carner, K., Chambers, K.S., Chinn, P.C., Leonard, J.E., Raab, R., et al. (1994) "Depletion of B-cells in vivo by a chimeric mouse human monoclonal antibody to CD20", Blood, 83, 435-445.
2. Coiffer, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., et al. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", New England Journal of Medicine, 346, 235-242.
3. Dervite, I., Hober, D. and Morel, P. (2001) "Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab", New England Journal of Medicine, 344, 68-69.
4. Lok, A.S.F., Liang, R.H.S., Chiu, E.K.W., Wong, K.L., Chan, T.K. and Tood, D. (1991) "Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy", Gastroenterology, 100, 182-188.
5. Treon, S.P., Mitsiades, C., Mitsiades, N., Young, G., Doss, D., Schlossman, R., et al. (2002) "Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies", Journal of Immunology, 24, 263-271.
6. Czuczman, M.S., Grillo-Lopez, A.J., White, C.A., Saleh, M., Gordon, L., Lobuglio, A.F., et al. (1999) "Treatment of patients with low grade B-cell lymphoma with the combination of chemeric anti-CD20 monoclonal antibody and CHOP chemotherapy", Journal of Oncology, 17, 268-276.
7. Ng, H.J. and Lim, L.C. (2001) "Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report", Annals of Hematology, 80, 549-552.
8. Skrabs, C., Muller, C., Agis, H., Mannhalter, C. and Jager, U. (2002) "Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge", Leukemia, 16, 1884-1886.
9. Al-Taie, O.H., Mork, H., Gassel, A.M., Wilhelm, M., Weissbrich, B. and Scheurlen, M. (1999) "Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature", Annals of Hematology, 78, 247-249.
10. Silvestri, F., Ermacora, A., Sperotto, A., Patriarca, F., Zaja, F., Damiani, D., et al. (2000) "Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation", British Journal of Haematology, 108, 394-396.
11. Mimidis, K., Tsatalas, C., Margaritis, D., Martinis, G., Spanoudakis, E., Kotsiou, S., et al. (2002) "Efficacy of lamivudine in patients with hematologic malignancies receiving chemotherapy and precore mutant chronic active hepatitis B", Acta Haematologica, 107, 49-51.
12. Hamaki, T., Kami, M., Kusumi, E., Ueyama, J., Miyakoshi, S., Morinaga, S., et al. (2001) "Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab", American Journal of Hematology, 68, 292-294.